Severe acute respiratory syndrome.
The first cases of severe acute respiratory syndrome (SARS) occurred in China in November 2002. The agent causing this illness has been identified as a novel coronavirus, SARS-coronavirus. Since its introduction <1 year ago, this virus has infected 8098 people in 26 countries, killing 774 of them. We present an overview of the epidemiology, clinical presentation, diagnosis, and treatment of SARS based on the current state of knowledge derived from published studies and our own personal experience.
Christian
Michael D
MD
Toronto General Hospital, University Health Network, Toronto, Ontario, Canada.
Poutanen
Susan M
SM
Loutfy
Mona R
MR
Muller
Matthew P
MP
Low
Donald E
DE
D000998:Antiviral Agents / Q000627:therapeutic use; D002681:China / Q000453:epidemiology; D021821:Communicable Diseases, Emerging / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D004196:Disease Outbreaks; D006801:Humans; D017053:Infection Control; D017758:Infectious Disease Transmission, Patient-to-Professional; D012254:Ribavirin / Q000627:therapeutic use; D045473:Severe acute respiratory syndrome-related coronavirus; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000503:physiopathology; D014944:World Health Organization
D000998:Antiviral Agents; D012254:Ribavirin